In 2023, the turnover of basic pharmaceutical products in Belgium stood at €1.05 billion. The forecasted data from 2024 to 2028 indicate a consistent upward trend in turnover, starting from €1.19 billion in 2024 and reaching €1.8 billion by 2028. Year-on-year variations show progressive growth: 12.7% for 2025, 11.2% for 2026, 10.7% for 2027, and 9.1% for 2028. The compound annual growth rate (CAGR) over this period is approximately 11.7%.
Future trends to watch for include:
- Advancements in pharmaceutical technology and innovation
- Regulatory changes impacting production and sales
- Global health demands and aging populations
- Market consolidation through mergers and acquisitions
- Shifts in healthcare funding and insurance coverage